GLP Watchdog

altRX vs Push Health

altRX has an open FDA warning letter dated June 8, 2026. Push Health has none. Push Health publishes no GLP-1 price we could capture. altRX starts at $89 a month for compounded semaglutide injection.

To see where both sit among the other sellers, read our best weight-loss injection providers board.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

altRX / Push Health

Featured pick (affiliate partner)

altRX logo

altRX

8.8/10

Push Health logo

Push Health

4.1/10

FDA warning letters
None on record
Pharmacy
  • RedRock Pharmacy503A
  • Health Warehousetype not stated
  • Precision Medicinetype not stated
  • and 1 more
None named in our record
Lowest standing price
$89/moCompounded semaglutide injection
No GLP-1 price published
States
All 50 states
No state list published
Checked
Prices captured Record checked October 2026
Prices captured Record checked September 2026
Visit altRX
Visit Push Health

altRX is our featured pick on this page because it is an affiliate partner: we are paid if you sign up through our link. Push Health pays us nothing. The scores are computed the same way for both and are shown as computed (altRX 8.8, Push Health 4.1). How we are paid

What the record shows

  1. 01

    altRX has an open FDA warning letter dated June 8, 2026. Push Health has none.

  2. 02

    altRX names four pharmacies. Push Health names no compounding pharmacy in our record.

  3. 03

    Push Health publishes no GLP-1 price we could capture. altRX starts at $89 a month for compounded semaglutide injection.

  4. 04

    Only altRX lists a price for compounded semaglutide injection, compounded tirzepatide injection and brand-name semaglutide pen.

  5. 05

    altRX lists all 50 states. Push Health publishes no state list.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

altRX

Push Health

Compounded semaglutide injection

$89/mo

$1,068 a year

Not sold or not priced
Compounded tirzepatide injection

$149/mo

$1,788 a year

Not sold or not priced
Brand-name semaglutide pen

$1,149/mo

$13,788 a year

Not sold or not priced
Brand-name tirzepatide pen

$1,249/mo

$14,988 a year

Not sold or not priced
Price includes
Medication, clinician visits, shipping
Not stated
Cancel any time
Yes, stated
Yes, stated
Minimum term
None on the monthly plan; multi-month plans are prepaid and non-refundable
None
Refunds
All payments are final and non-refundable, except a partial refund if you are medically disqualified
Full refund if you cancel before the provider writes a prescription; none after

Read off each seller’s own pages. altRX: September 28, 2026. Push Health: September 28, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for altRX

8.8/10
Featured pick (affiliate partner)
  • Sells compounded semaglutide injection and compounded tirzepatide injection, which Push Health does not price
  • Open FDA warning letter, June 8, 2026
Visit altRX

The case for Push Health

4.1/10
  • No FDA warning letter on record
  • Names no compounding pharmacy
  • Publishes no state list
  • Publishes no GLP-1 price
Visit Push Health

Scores

altRX 8.8 · Push Health 4.1 out of 10. Six weighted parts.

Value25%

10.0A
vs
B
3.0

Effectiveness25%

10.0A
vs
B
5.0

User Experience15%

8.0A
vs
B
3.0

Trust & Safety15%

6.0A
vs
B
4.0

Accessibility10%

10.0A
vs
B
5.0

Support10%

7.0A
vs
B
5.0

The score is the same formula for every seller. Payment does not enter it. Method

altRX vs Push Health: questions

altRX has an open FDA warning letter dated June 8, 2026. Push Health has none. Letters are matched to a seller by company, domain and address, never by a similar name.
altRX names four pharmacies. Push Health names no compounding pharmacy in our record. A 503A pharmacy compounds for named patients on a prescription; a 503B outsourcing facility is registered with FDA and inspected under federal manufacturing rules.
altRX states you can cancel at any time; refunds: all payments are final and non-refundable, except a partial refund if you are medically disqualified. Push Health states you can cancel at any time; refunds: full refund if you cancel before the provider writes a prescription; none after.
altRX is our featured pick on this page because it is an affiliate partner: we are paid if you sign up through our link. Push Health pays us nothing. The scores are computed the same way for both and are shown as computed (altRX 8.8, Push Health 4.1).

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks